Immediate Implants in extraction sockets with periapical lesions

Immediate Implants in extraction sockets with periapical lesions: A Prospective study - NIL

Status

Active, not recruiting

Phases

Phase 3Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/05/067904

Enrollment

Registered

2024-05-27

Start date

Unknown

Completion date

Unknown

Last updated

2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical Health Condition 2: K088- Other specified disorders of teethand supporting structures

Interventions

Intervention1: imeediate implantation in extraction socket with periapical lesion: After traumatically extracting the teeth with periapical pathology, the alveolae will undergo meticulous curettage an

in case of penicillin allergy, 300 mg clindamycin w

Eligibility

Inclusion criteria

Inclusion criteria: 1.Age 18-65 years of both gender 2.Immediate implants in the aesthetic zones only 3.ASA1 and 2 4.Buccal bone should be upto or greater than midroot level of the tooth. 5.Adequate bone at least 2-3 mm beyond the apex of the tooth or beyond the peri-apical lesion 6.In case of larger peri-apical lesions needing apical buccal access for curettage, adequate 3 dimensional bone should be present cervically.

Exclusion criteria

Exclusion criteria: 1.Medically compromised patients. 2.Presence of acute peri-apical pathology 3.Smoking and tobacco users 4.Patient undergoing chemotherapy and radio therapy 5.Pregnant and lactating patients 6.ASA 3 and 4 7.Bone less than 2 mm beyond the apex of the tooth or beyond the peri-apical area

Design outcomes

Primary

Measure	Time frame
1.RFA to check the implant bone stability at baseline and at 4months of follow up 2.CBCT at baseline and at 4 months of follow up to evaluate the thickness of the labial bone 3. VAS score for presence of pain at week 1 of follow up Timepoint: 1.RFA to check the implant bone stability at baseline and at 4months of follow up 2.CBCT at baseline and at 4 months of follow up to evaluate the thickness of the labial bone 3. VAS score for presence of pain at week 1 of follow up	—

Measure

Time frame

1.RFA to check the implant bone stability at baseline and at 4months of follow up 2.CBCT at baseline and at 4 months of follow up to evaluate the thickness of the labial bone 3. VAS score for presence of pain at week 1 of follow up Timepoint: 1.RFA to check the implant bone stability at baseline and at 4months of follow up 2.CBCT at baseline and at 4 months of follow up to evaluate the thickness of the labial bone 3. VAS score for presence of pain at week 1 of follow up

—

Secondary

Measure	Time frame
Hisptopathological findings of study group VAS score for presence of pain at week 1 of follow up Timepoint: baseline and week 1 of follow up	—

Countries

India

Contacts

Public ContactJason Nongmaithem

ITS CDSR Ghaziabad

tushar.dubey123@gmail.com8077018989

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026